Prospective cohort studies indicate a correlation between elevated levels of IL-6/CRP and subsequent risk of physical and neuropsychiatric illnesses such as cancers, coronary heart disease, type 2 diabetes, Alzheimer's disease, depression and psychosis [6–12]. This evidence concerns the gene CRP and depressive symptom measurement.